Psychosis News and Research

RSS

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''

Having flu when pregnant increases risk of schizophrenia in offspring

When mothers become infected with influenza during their pregnancy, it may increase the risk for schizophrenia in their offspring. Influenza is a very common virus and so there has been substantial concern about this association. A new study in the June 15th issue of Biological Psychiatry, published by Elsevier suggests that the observed association depends upon a pre-existing vulnerability in the fetus.

9 Jun 2009

Marijuana effectiveness as an HIV self-care strategy

Those in the United States living with HIV/AIDS are more likely to use marijuana than those in Kenya, South Africa or Puerto Rica to alleviate their symptoms, according to a new study published in Clinical Nursing Research, published by SAGE.

31 May 2009

Low birth weight linked to psychosis-like symptoms

Low birth weight babies are at greater risk of developing psychosis-like symptoms as they grow up, research suggests. The study, published in the June issue of the British Journal of Psychiatry, shows a link between children's size at birth and their mental health at the age of 12.

28 May 2009

FDA approve Fanapt tablets (iloperidone) to treat adults with schizophrenia

The U.S. Food and Drug Administration has approved Fanapt tablets (iloperidone) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder.

7 May 2009

Potential molecular target for new schizophrenia treatments

A study on schizophrenia has implicated machinery that maintains the flow of potassium in cells and revealed a potential molecular target for new treatments. Expression of a previously unknown form of a key such potassium channel was found to be 2.5 fold higher than normal in the brain memory hub of people with the chronic mental illness and linked to a hotspot of genetic variation.

5 May 2009

Children bullied at school more likely to develop psychotic-like symptoms

Children who are bullied at school over several years are up to four times more likely to develop psychotic-like symptoms by the time they reach early adolescence.

4 May 2009

Aussies wanted for international groundbreaking study on depression

Australians researchers have put out a call for 400 people to take part in a study on depression.

26 Apr 2009

Seroquel XR supplemental NDA recommended for approval

The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) conducted a review of the safety and efficacy of supplemental new drug applications (sNDA) for Seroquel XR (quetiapine fumarate) extended-release tablets proposed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).

9 Apr 2009

Health problems associated with Chinese slimming capsules

Taking herbal food supplements is certainly not free of risk. Since 2005, the poison emergency centers in the German cities of Freiburg and Gottingen have registered a total of 17 patients with health problems after taking Chinese slimming capsules.

8 Apr 2009

Schizophrenics appear to rely considerably less on top-down processing during perception

Patients with schizophrenia are able to correctly see through an illusion known as the 'hollow mask' illusion, probably because their brain disconnects 'what the eyes see' from what 'the brain thinks it is seeing', according to a joint UK and German study published in the journal NeuroImage.

6 Apr 2009

FDA approves Symbyax for treatment-resistant depression

The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company has announced.

23 Mar 2009

Shire withdraws European application for Daytrana (Methylphenidate Transdermal System)

Shire plc has announced that it has decided to withdraw the European Marketing Authorization Application (MAA) for Daytrana (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

16 Mar 2009

Postnatal psychosis more common in older first-time mothers

Women who give birth for the first time after the age of 35 run a greater risk than younger first-time mothers of suffering a psychosis in the months after delivery.

10 Feb 2009

First-time mothers at a greater risk of psychosis in the month following childbirth

A study of risk factors associated with psychotic illness after childbirth, published this week in the open-access journal PLoS Medicine, shows that first-time mothers are at the greatest risk of developing psychosis in the month following the birth of their child - even if they have never been treated in hospital for mental illness in the past.

10 Feb 2009

Older first time mothers more prone to develop mental illness

Swedish researchers have revealed that women who have their first baby after age 35 are more likely to develop a mental illness after the birth.

10 Feb 2009

Mum who tried to poison her children placed on good-behaviour bond

An Australian woman who tried to poison her two children last year has been placed on a good-behaviour bond after pleading guilty to the charge of intending to harm them.

10 Feb 2009

Volunteers needed for hydrocortisone in treatment resistant depression research

Can hydrocortisone, a drug which affects the body's stress system, help people with depression who do not respond to current treatments?

5 Feb 2009

Schizophrenia and bipolar disorder have same genetic causes

Schizophrenia and bipolar disorder have for decades been regarded as two distinct psychotic disorders when it comes to definitions and risk factors.

21 Jan 2009

Lack of grey matter linked to schizophrenia and bipolar disorder

A research study led by scientists from the Gregorio Marañón University Hospital in Madrid and the Network of Centres for Biomedical Research in Mental Health Networks (CIBERSAM) shows that adolescents experiencing a first outbreak of psychosis have lower levels of grey matter in their brains than healthy teenagers. Strangely, this change was seen in patients suffering from various psychoses, including bipolar illness and schizophrenia.

19 Jan 2009

Eli Lilly to pay $1.415 billion for off-label promotion of Zyprexa

American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA), the Department of Justice announced today.

19 Jan 2009